Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance.
about
Metastatic melanoma moves on: translational science in the era of personalized medicine.Strategies for Overcoming Resistance in Tumours Harboring BRAF Mutations.Acetylsalicylic acid inhibits the growth of melanoma tumors via SOX2-dependent-PAF-R-independent signaling pathway.Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016.Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells.LKB1 loss cooperating with BRAF V600E promotes melanoma cell invasion and migration by up-regulation MMP-2 via PI3K/Akt/mTOR pathway.DNA Mutations May Not Be the Cause of Cancer.Embryonic bone morphogenetic protein and nodal induce invasion in melanocytes and melanoma cells.MEK inhibition and immune responses in advanced melanoma.Targeted Tumor Therapy Remixed-An Update on the Use of Small-Molecule Drugs in Combination Therapies.SwissMTB: establishing comprehensive molecular cancer diagnostics in Swiss clinicsPlasticity of differentiated cells in wound repair and tumorigenesis, part II: skin and intestine
P2860
Q38891959-9C301D86-71A7-4FB1-8256-B7269CF0189AQ39173195-40AF0F34-53D3-4172-A52B-85EDFAD5CE9BQ41472852-86B27C80-4283-4E8C-8EE6-F2415B313B1EQ46721978-72F36525-601B-41E2-8CC2-E32F4B8F078DQ47227422-17B7D102-FF94-4E48-B531-C12CF7FF26C4Q48523000-FD7B2A00-2183-44BF-840E-74CD8F847DF1Q53725947-AC4F76FD-263A-4183-9377-4ADD8A4A41CFQ53827045-E222B0E2-81AB-45AC-83E6-20BCA7847A05Q54146041-5BBD3180-2703-46FE-9B5B-CACE05A05430Q54978342-AD0BF70C-A638-4B16-8A52-528F1A5D6A67Q58101254-A0DB3B62-C60E-4AD4-81F8-42FF66727F5AQ58778696-30F67268-F1D3-4119-8FC0-4A693AEDED5C
P2860
Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Co-existence of BRAF and NRAS ...... f targeted therapy resistance.
@ast
Co-existence of BRAF and NRAS ...... f targeted therapy resistance.
@en
type
label
Co-existence of BRAF and NRAS ...... f targeted therapy resistance.
@ast
Co-existence of BRAF and NRAS ...... f targeted therapy resistance.
@en
prefLabel
Co-existence of BRAF and NRAS ...... f targeted therapy resistance.
@ast
Co-existence of BRAF and NRAS ...... f targeted therapy resistance.
@en
P2093
P2860
P356
P1433
P1476
Co-existence of BRAF and NRAS ...... of targeted therapy resistance
@en
P2093
Apurva Narechania
Daniel S Widmer
Daniela Mihic-Probst
Judith Wenzina
Marieke I G Raaijmakers
Ossia Eichhoff
Reinhard Dummer
Rob Desalle
Sandra N Freiberger
P2860
P304
77163-77174
P356
10.18632/ONCOTARGET.12848
P407
P577
2016-11-01T00:00:00Z